| Literature DB >> 28693802 |
Paolo Bossi1, Maria Cossu Rocca2, Renzo Corvò3, Roberta Depenni4, Vittorio Guardamagna5, Franco Marinangeli6, Francesco Miccichè7, Fabio Trippa8.
Abstract
The intensity of the available treatment approaches for locally-advanced head and neck cancer (HNC) is at the upper limit of tolerance of acute toxicities. Several factors including breakthrough cancer pain, mucositis, dysphagia, local and systemic infections, and nutritional problems are related to treatment intensity. Particularly, pain, as symptom directly associated with the disease or combined with other treatment-related factors, has a major impact on quality of life of HNC patients and ultimately can influence the efficacy of treatments in HNC. Here, a Multidisciplinary Board of Italian Experts has addressed these issues, with the aim to identify the unmet need and appropriate strategies for the maintenance of optimal treatment intensity in HNC.Entities:
Keywords: Breakthrough cancer pain; Concurrent chemoradiotherapy; Dysphagia; Head and neck cancer; Mucositis; Quality of life; Treatment intensity
Mesh:
Year: 2017 PMID: 28693802 DOI: 10.1016/j.critrevonc.2017.05.012
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN: 1040-8428 Impact factor: 6.312